ResearchIn-Press PreviewAIDS/HIVImmunology
Open Access | 10.1172/jci.insight.167329
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by
Carmona-Perez, L.
in:
JCI
|
PubMed
|
Google Scholar
|
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by Dagenais-Lussier, X. in: JCI | PubMed | Google Scholar
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by
Mai, L.
in:
JCI
|
PubMed
|
Google Scholar
|
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by
Stögerer, T.
in:
JCI
|
PubMed
|
Google Scholar
|
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by Swaminathan, S. in: JCI | PubMed | Google Scholar
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by Isnard, S. in: JCI | PubMed | Google Scholar
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by Rice, M. in: JCI | PubMed | Google Scholar
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by
Barnes, B.
in:
JCI
|
PubMed
|
Google Scholar
|
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by
Routy, J.
in:
JCI
|
PubMed
|
Google Scholar
|
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by van Grevenynghe, J. in: JCI | PubMed | Google Scholar
1Immunology and Infectious Diseases, INRS - Centre Armand-Frappier, Laval, Canada
2Division of Hematology and Chronic Viral Illness Service, McGill University Health Centre Research Institute, Montréal, Canada
3Center for Autoimmune Musculoskeletal and Hematopoietic Diseases, Feinstein Institutes for Medical Research, Manhasset, United States of America
4Feinstein Institutes for Medical Research, Manhasset, United States of America
5INRS - Centre Armand-Frappier, Laval, Canada
Find articles by Stager, S. in: JCI | PubMed | Google Scholar
Published May 25, 2023 - More info
HIV-1 infection is characterized by a strong inflammatory environment, tissue disruption, and a progressive decline in CD4+ T cell count. Despite treatment with antiretroviral therapy (ART), the majority of persons living with HIV (PLWH) maintain residual levels of inflammation, low degree of immune activation, and higher sensitivity to cell death in their memory CD4+ T-cell compartment. To date, the mechanisms responsible for this high sensitivity remain elusive. We have identified the transcription factor IRF-5 to be involved in impairing the maintenance of murine CD4+ T cells in a chronic inflammatory environment. Here, we investigate whether IRF-5 also contributes to memory CD4+ T cell loss during HIV-1 infection.
We show that TLR7 and IRF-5 were upregulated in memory CD4+ T cells from PLWH, when compared with naturally protected elite controllers and HIVfree participants. TLR7 was upstream of IRF-5, promoting Caspase 8 expression in CD4+ T cells from ART HIV-1+ but not from HIVfree participants. Moreover, IRF-5 and TLR7 expression inversely correlated with CD4+ T cell counts in primary HIV infection. Interestingly, the TLR7-IRF-5 axis acted synergistically with the Fas/FasL pathway, suggesting that TLR7 and IRF-5 expression in ART HIV-1+ memory CD4+ T cells represents an imprint that predisposes cells to Fas-mediated apoptosis. This predisposition could be blocked using IRF-5 inhibitory peptides. Thus, we propose IRF-5 blockade as a possible therapy to prevent memory CD4+ T cell loss in PLWH.